CHRISTINA FLECK: Open Payments
NPI 1720719990 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$203 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $203
Food & beverage: $203
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: JARDIANCE, Auvelity, REXULTI, AIRSUPRA, Ozempic, EVENITY, MOUNJARO, FARXIGA.
Industry payments across IN — which companies pay providers there.
